AN ACT RELATING TO BUSINESSES AND PROFESSIONS -- THE PRESCRIPTION DRUG SALES REPRESENTATIVE DISCLOSURE ACT
Summary
Requires prescription drug manufacturers to file a detailed, updated list of each pharmaceutical sales representative engaged by the manufacturer and to pay an annual fee for each name listed with the department of business regulation.
Bill status
died
1 of 4 stages cleared
Introduction
Feb 2025
Committee Review
Floor Vote
Governor
Introduced Feb 26, 2025
Last action Mar 6, 2025
Floor votes
How they voted
No floor votes recorded yet.
Full legislative history
Actions timeline
Total actions
3
Key actions
0
Committee
1
Mar 6, 2025
Committee
03/06/2025 Committee recommended measure be held for further study
legislature
Feb 26, 2025
Introduced
02/26/2025 Introduced, referred to House Health & Human Services
lower
10 primary · 0 co-sponsors
Sponsors
Ask Maddy
·
AI policy assistant
Ask Maddy about HB 5632
Scope: RI
Hi! I can help you understand HB 5632. What would you like to know?
Try one of these
i
Maddy answers using official bill text and legislative records. Always verify before sharing.
Sources cited inline